Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases - Indication - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-02-01 04:42:51 Chemistry Medicine Clinical medicine Breakthrough therapy Carbamates Cyclopropanes Infectious causes of cancer Sulfonamides Simeprevir Sofosbuvir Ombitasvir/paritaprevir/ritonavir Telaprevir		Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases Add to Reading List Source URL: www.hepatitis-schweiz.ch Download Document from Source Website File Size: 142,28 KB Share Document on Facebook

	Breakthrough Cancer Therapy DTC DocID: 1sYyU - View Document
	Microsoft Word - GILEAD BRIEFING DocID: 1r2Vm - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1qWZQ - View Document
	24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box DocID: 1qVSm - View Document
	12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY O DocID: 1qRuM - View Document